Hepatobiliary disease in inflammatory bowel disease

被引：10

作者：

Ahmad, J ^{[1
]}

Slivka, A ^{[1
]}

机构：

[1] UPMC Presbyterian, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA

来源：

GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2002年 / 31卷 / 01期

关键词：

D O I：

10.1016/S0889-8553(01)00020-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

There are a number of hepatobiliary diseases seen in IBD. PSC is the most common, occurring in up to 7.5% of patients with ulcerative colitis. The etiology of PSC is not well understood but appears to occur on the background of genetic susceptibility, sharing some immunological abnormalities with ulcerative colitis. A characteristic cholangiogram in a patient with abnormal liver injury tests usually establishes the diagnosis. Liver biopsy is not essential but can help make the diagnosis of small duct PSC in patients with a normal cholangiogram. There are no medications that effectively treat PSC. Endoscopic dilation of dominant strictures reduces the frequency of cholangitis and may improve survival. OLT remains the only proven treatment of advanced PSC. Cholangiocarcinoma is a feared complication of PSC that is difficult to diagnose. Cholelithiasis, PBC, portal vein thrombosis, and hepatic abscess are hepatobiliary disorders that occur less frequently in IBD patients.

引用

页码：329 / +

页数：18

共 131 条

[31] PORTAL-VEIN THROMBOSIS IN A COMPLICATED CASE OF CROHNS-DISEASE [J].

CROWE, A ;

TAFFINDER, N ;

LAYER, GT ;

IRVINE, A ;

NICHOLLS, RJ .

POSTGRADUATE MEDICAL JOURNAL, 1992, 68 (798) :291-293

[32] Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis [J].

Cruickshank, SM ;

Southgate, J ;

Wyatt, JI ;

Selby, PJ ;

Trejdosiewicz, LK .

JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (10) :730-734

[33] A SHARED AND UNIQUE EPITOPE(S) ON HUMAN-COLON, SKIN, AND BILIARY EPITHELIUM DETECTED BY A MONOCLONAL-ANTIBODY [J].

DAS, KM ;

VECCHI, M ;

SAKAMAKI, S .

GASTROENTEROLOGY, 1990, 98 (02) :464-469

[34]

de Wit AWMV, 1999, EUR J GASTROEN HEPAT, V11, P129

[35] Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis [J].

deWit, AWMV ;

vanBracht, J ;

Rauws, EAJ ;

Jones, EA ;

Tytgat, GNJ ;

Huibregtse, K .

GASTROINTESTINAL ENDOSCOPY, 1996, 44 (03) :293-299

[36] End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients [J].

Dodd, GD ;

Baron, RL ;

Oliver, JH ;

Federle, MP .

RADIOLOGY, 1999, 211 (02) :357-362

[37] LITHOGENIC BILE IN PATIENTS WITH ILEAL DYSFUNCTION [J].

DOWLING, RH ;

BELL, GD ;

WHITE, J .

GUT, 1972, 13 (06) :415-&

[38] PRIMARY SCLEROSING CHOLANGITIS - LIVER-TRANSPLANTATION OR BILIARY SURGERY [J].

FARGES, O ;

MALASSAGNE, B ;

SEBAGH, M ;

BISMUTH, H .

SURGERY, 1995, 117 (02) :146-155

[39]

FARKKILA MA, 1988, SURGERY, V104, P18

[40] AMINO-ACID SUBSTITUTIONS AT POSITION-38 OF THE DR-BETA POLYPEPTIDE CONFER SUSCEPTIBILITY TO AND PROTECTION FROM PRIMARY SCLEROSING CHOLANGITIS [J].

FARRANT, JM ;

DOHERTY, DG ;

DONALDSON, PT ;

VAUGHAN, RW ;

HAYLLAR, KM ;

WELSH, KI ;

EDDLESTON, ALWF ;

WILLIAMS, R .

HEPATOLOGY, 1992, 16 (02) :390-395

← 1 2 3 4 5 6 7 8 9 10 →